Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 25, 2013
Patent Application Number
11105041
Date Filed
April 13, 2005
Patent Primary Examiner
Patent abstract
The present invention is directed toward the delivery of a toxic protein to pathogenic cells, particularly cancer cells. In preferred embodiments, the toxic protein is a ribonuclease that has been modified to make it toxic to target cells and that can be conjugated to a target cell-specific delivery vector, such as an antibody, for delivery to pathogenic cells.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
